Clinical references and scope
Chronic rhinosinusitis
Diagnostic overview
Adult chronic rhinosinusitis; not the complete nose/throat family.
AAO-HNSF: 2025 Adult Sinusitis Update, key action statements
Scope of this clinical reference
- Complete symptom/duration framework, phenotypes and other nose/throat diagnoses remain open.
Professional assessments
Evidence and examination topics
- Diagnosis and history: Records identifying the current diagnosis, onset, course, and relevant medical history.
- Diagnostic tests and measurements: Condition-relevant tests, imaging, laboratory results, and objective measurements.
- Symptoms and episodes: Records or statements documenting symptoms, severity, frequency, duration, and episodes.
- Clinical findings: Examination findings that are relevant to the public DBQ or rating criteria.
- Scars and residual findings: Records describing relevant scars and residual physical findings.
- Functional impact: Medical and lay evidence describing work and daily-activity effects.
- Service connection evidence: Evidence addressing an in-service event, exposure, disease, injury, continuity, or a secondary relationship.
What the VA questionnaire covers
Source version 26_2; updated 2026-04-07. Use the original questionnaire for the complete wording and exceptions.
- diagnosis · source pages 1, 2
- medical history · source pages 2
- nose, throat, larynx or pharynx conditions · source pages 3
- sinusitis · source pages 3, 4
- rhinitis · source pages 4
- larynx and pharynx conditions · source pages 4, 5, 6
- deviated nasal septum · source pages 6
- tumors and neoplasms · source pages 6, 7
- other pertinent physical findings, complications, conditions, signs, symptoms, and scars · source pages 7, 8
- diagnostic testing · source pages 8, 9
- functional impact · source pages 9
- remarks · source pages 9
Full rating rules and tables
Understand service-connection and nexus evidence →Related rating guides
Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.